Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

X-reactivation as an approach to treating Rett Syndrome

Tue19 Oct04:30pm(30 mins)
Where:
Hall 1B
Speaker:

Abstract

The human X chromosome harbors only 4% of our genes but over 20% of loci associated with intellectual disability. Because they inherit only one X-chromosome, males are more frequently affected by X-linked neurodevelopmental genetic disorders. Despite inheriting two X-chromosomes, however, females can also be affected because X-chromosome inactivation (XCI) enables only one of two X chromosomes to be expressed per cell. Notable examples include Rett, CDKL5, and Fragile X syndromes. For these disorders, disease-specific treatments have remained elusive. In female subjects, a cure may be found within their own cells, as every sick cell carries a healthy copy of the affected gene on the inactive X (Xi). Selective Xi-reactivation may therefore be a viable approach that would address the root cause of various X-linked disorders. We will discuss current approaches to reactivate the silent MECP2 allele.

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2374